Thanks sab63090
... I trust in good science, do the best I can to especially understand breakthrough therapies and hope this turns out well for all longs.
That was a a glaring slip, again in my humble opinion on Miisslings part and wish I would have moved quicker to protect my investment here. CEO's don't make that type of mistake in regard to such an important upcoming binary event.
That being said I have lost trust in MIssling. I met and him and Sandra early on at a couple of annual shareholder meetings as I live here in manmhattan.
Do you remember Misslings insider buys many years ago? There were a few days in a row that he purchased somewhere around 375 shares, yes I said 375 each day. What was that, lol, and good for him and Sandra to have the insight to sell shares on the open market when the share price soared to the $30 range back in 2020. I'm not going to back check but I believe Sandra's proceeds were in the $4M range. Not bad for a PFO...
One can dream that upon re-examination, or even the possibility of the December opinion turning positive after OE, that the company is aligned with a partner to execute a successful transition to commercialization (geez, did I just say that!)
Market Data 
Markets 
AI
